TUESDAY, March 25, 2025 (HealthDay News) — Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called UBT251, is being developed by United Bio-Technology (Hengqin) Co.,Continue Reading
MONDAY, March 24, 2025 (HealthDay News) — People dealing with heart disease, diabetes or obesity are behind the eight ball when it comes to their chances of living longer. But they can improve their odds if they start following a healthy plant-based diet, according to a study scheduled for presentationContinue Reading
WEDNESDAY, March 12, 2025 (HealthDay News) — Purposeful splishing and splashing can help you trim your waist size and drop excess pounds, a new evidence review has concluded. Water aerobics led to about 6 pounds of weight loss and more than an inch off the waists of overweight and obeseContinue Reading
FRIDAY, March 7, 2025 (HealthDay News) — The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish company behind Wegovy, announced Wednesday that it has lowered its monthly cost by 23%.Continue Reading
TUESDAY, March 4, 2025 (HealthDay News) — More than half of adults and a third of children and teens worldwide will be overweight or obese by 2050, a comprehensive global analysis has concluded. Overweight and obesity rates in adults, children and teens more than doubled over the past three decades,Continue Reading
FRIDAY, Feb. 28, 2025 (HealthDay News) — GLP-1 drugs like Ozempic/Wegovy don’t increase a person’s risk of suicidal actions or thoughts, a new study has concluded. Earlier research had potentially linked these drugs — which are used to treat type 2 diabetes and obesity — with suicidal thoughts and self-harm,Continue Reading
MONDAY, Feb. 24, 2025 (HealthDay news) — Even slight weight loss spurred on by cutting-edge GLP-1 drugs can help prevent replacement knees and hips from wearing out, a new study suggests. People with new knees and hips are significantly less likely to need follow-up surgery to fix wear and tearContinue Reading
TUESDAY, Feb. 18, 2025 (HealthDay News) – Juice cleanses are a popular way to kickstart a health journey, but these diets may do more harm than good in as little as three days. A study published recently in the journal Nutrients found that consuming vegetable and fruit juice-only diets for threeContinue Reading
WEDNESDAY, Feb. 12, 2025 (HealthDay News) — Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their intake. The research found that, compared to placebo, weekly injections of semaglutide (also marketed for weight loss as Wegovy) helped reduce cravings in peopleContinue Reading
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — “Yo-yo” dieting — repeatedly losing and gaining weight — can significantly increase risk of kidney disease among people with type 1 diabetes, a new study warns. Diabetics with greater weight fluctuations experienced a 40% decline in their kidneys’ ability to filter toxins fromContinue Reading